CDK5 and prostate carcinoma: Furthermore, treatment with siRNA of CDK5 or inhibitors reduced Digoxin-triggered prostate cancer cell death, suggesting that CDK5 plays an essential role in Digoxin-triggered prostate cancer cell death.